Home › Research › Risk factors
Dementia care in diverse older adults in the Deep South and the rest of the United States
Maria Pisu, Roy C. Martin, Liang Shan, Giovanna Pilonieta, Richard Kennedy, Gabriela R. Oates, Young-il Kim, David Geldmacher. Alzheimer s & Dementia, 2021-12-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Abstract Background Prevalence of Alzheimer’s disease and related dementia (ADRD) is increasing especially in the southeastern US. For older adults with ADRD, gaps exist in utilization of specialists (neurologists, psychiatrists, geriatricians) and ADRD drugs, e.g., across racial/ethnic (R/E) patient groups. Because some R/E groups, e.g., African Americans (AAs), are overrepresented in the Southeast, closer scrutiny of their ADRD care is needed. Within the Southeast, the Deep South (DS) includes some of the poorest US states (Alabama, Mississippi, Louisiana, Georgia, and South Carolina). We examined R/E disparities in specialist and drug utilization in DS vs. non‐DS states, and examined individual and context‐level factors that impact utilization in each region. Methods Population, outcomes, and individual‐level covariates were identified from claims for fee‐for service Part A/B (hospital, outpatient) and D (prescription drugs) Medicare beneficiaries in 2013‐2015 (66 and older). For context‐level covariates, we combined Area Health Resource File county‐level data in exploratory factor analysis (EFA). We conducted adjusted analyses for DS and non‐DS with outcomes: 1) ≥ 1 specialist visit; and 2) ≥ 1 prescription for donepezil, galantamine, rivastigmine, or memantine. R/E groups included AAs, Non‐Hispanic Whites, Hispanic, Asian/Pacific Islander, and Other. Results We identified 127,512 Medicare beneficiaries with ADRD (9.4% in DS). Specialist utilization ranged from 37% AAs to 42% Whites in DS, 45% Whites to 50% AAs in non‐DS. ADRD drug utilization ranged from 48% AAs to 55% Hispanics in DS, 42% AAs to 48% Hispanics in non‐DS. EFA identified 4 context‐level factors with two common to DS and non‐DS. R/E disparities were not significant, except for non‐DS Asian/Pacific Islanders vs. Whites (RR 0.81, CI = 0.777‐0.849, p<.0001). In DS and non‐DS, comorbidities, poverty, and EFA factor “Medical Resources Availability” were associated with utilization outcomes. No other factor was associated with outcomes in DS. In non‐DS, factors “Population Health”, “Health Insurance Market” were associated with outcomes. Conclusion ADRD specialist and drug utilization is relatively low in both DS and non‐DS, with no significant R/E differences. Research should continue to examine factors that may drive medical care decisions of older adults with ADRD in US regions with different socio‐economic and medical resource contexts.
What this study adds
Evidence grade: Low
This study examined racial and ethnic differences in specialist visits and dementia drug prescriptions among Medicare beneficiaries in the Deep South versus the rest of the US. Reported effect size: 9.4%; RR 0.81.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Pisu, M., Martin, R. C., Shan, L., Pilonieta, G., Kennedy, R., Oates, G. R., et al. (2021). Dementia care in diverse older adults in the Deep South and the rest of the United States. Alzheimer s & Dementia. https://doi.org/10.1002/alz.054038
Vancouver
Pisu M, Martin RC, Shan L, Pilonieta G, Kennedy R, Oates GR, et al. Dementia care in diverse older adults in the Deep South and the rest of the United States. Alzheimer s & Dementia. 2021. doi:10.1002/alz.054038.
BibTeX
@article{pisu2021-3ac95d77,
author = {Pisu, Maria and Martin, Roy C. and Shan, Liang and Pilonieta, Giovanna and Kennedy, Richard and Oates, Gabriela R. and Kim, Young-il and Geldmacher, David},
title = {{Dementia care in diverse older adults in the Deep South and the rest of the United States}},
journal = {Alzheimer s \& Dementia},
year = {2021},
doi = {10.1002/alz.054038},
url = {https://doi.org/10.1002/alz.054038}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Results We identified 127,512 Medicare beneficiaries with ADRD (9.4% in DS).
- R/E disparities were not significant, except for non‐DS Asian/Pacific Islanders vs.
- In DS and non‐DS, comorbidities, poverty, and EFA factor “Medical Resources Availability” were associated with utilization outcomes.
- No other factor was associated with outcomes in DS.
- In non‐DS, factors “Population Health”, “Health Insurance Market” were associated with outcomes.
Why it matters
This study examined racial and ethnic differences in specialist visits and dementia drug prescriptions among Medicare beneficiaries in the Deep South versus the rest of the US. It is about access to care, not about treating, curing or preventing Alzheimer's disease.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Effect size9.4%; RR 0.81
- Evidence strengthLow
How this study scored 31/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2021 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 7 year(s) since 2021 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author David Geldmacher: h-index 55 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Alabama at Birmingham: institution h-index 1,118 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 31 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk factors from nearby years
Also tagged “prevalence”
1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.